UPDATE: Taro Pharma (TARO) Reports Q1 EPS of $2.59
Tweet
Share
E-mailGet Alerts TARO Hot Sheet
Join SI Premium – FREE
(Updated - August 10, 2016 5:14 PM EDT)
(Updated to reflect Q1 results, not Q4)
Taro Pharma (NYSE: TARO) reported Q1 EPS of $2.59, versus $2.42 reported last year. Revenue for the quarter came in at $233.8 million, versus $215.3 million reported last year.
For earnings history and earnings-related data on Taro Pharma (TARO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Palogic urges Granite Point Mortgage to cut costs, halt new loans
- Benchmark Reiterates Buy Rating on H World Group Ltd. (HTHT) Following Q2 Print
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
